Overview Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults Status: Completed Trial end date: 2012-03-01 Target enrollment: Participant gender: Summary The purpose of the study is to evaluate the effects of a high fat meal on the pharmacokinetics of a single dose of 30 mg apremilast in healthy adults. Phase: Phase 1 Details Lead Sponsor: AmgenCelgene CorporationTreatments: ApremilastThalidomide